DLG4 and neuroblastoma: According to the study of Yin and colleagues in 201530, asiaticoside, which is the other major active constituent of ECa 233, also promoted the expression of p-Akt, GSK-3, synaptophysin (SYN) and PSD-95 in high glucose-treated neuroblastoma cells30.